Participants 1 133 5
Comparative effects of nebivolol and valsartan on atrial electromechanical coupling in newly diagnosed stage 1 hypertensive patients
Participants 659 758 7
The study included 60 newly diagnosed stage 1 hypertensive patients with no other systemic disease.
Participants 791 952 3
receive nebivolol 5 mg (30 patients; 21 women, 9 men; mean age 48.4 ± 11.4 years) and valsartan 160 mg (30 patients; 21 women, 9 men; mean age 49.8 ± 11.3 year
